Acompanhamento farmacoterapêutico dos pacientes com leucemia mieloide crônica em uso de mesilato de imatinibe na Universidade Federal do Ceará The pharmacotherapeutic follow- up of patients with chronic myeloid leukemia (CML) on imatinib mesylate therapy

Acompanhamento farmacoterapêutico dos pacientes com leucemia mieloide crônica em uso de mesilato de imatinibe na Universidade Federal do Ceará The pharmacotherapeutic follow- up of patients with chronic myeloid leukemia (CML) on imatinib mesylate therapy

Leucemia mieloide crônica (LMC) é uma desordem genética de etiologia desconhecida, caracterizada por crescimento aumentado e não regulado de células precursoras mieloides na medula óssea. LMC está associada com uma característica translocação cromossômica chamada de cromossoma Philadelphia. Esse é u...

Full description

Bibliographic Details
Main Authors:	Sterfen S. Aquino, Romélia P. Gonçalves, Lilianne B. Silva
Format:	Article
Language:	English
Published:	Elsevier 2009-01-01
Series:	Revista Brasileira de Hematologia e Hemoterapia
Subjects:	Leucemia mieloide crônica mesilato de imatinibe acompanhamento farmacoterapêutico Chronic myeloid leukemia imatinib mesylate pharmacotherapeutic follow- up
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842009000300007

Similar Items

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate
by: Vaneuza M. Funke, et al.
Published: (2008-04-01)

Therapy of chronic myeloid leukemia with imatinib mesylate in Brazil: a study of 98 cases Tratamento da leucemia mielóide crônica com imatinib mesilato no Brasil: estudo de 98 casos
by: Vaneuza A. M. Funke, et al.
Published: (2005-09-01)

Falla cardiaca asociada con el uso de imatinib mesilato: Reporte de un caso Heart failure associated to imatinib mesylate use: Case report
by: Clara Saldarriaga, et al.
Published: (2008-12-01)

Aplasia irreversible por el tratamiento con mesilato de Imatinib en una leucemia mieloide crónica: Presentación de un caso Irreversible aplasia due to the treatment with imatinib mesilate in a chronic myeloid leukemia: A case report
by: Olga Agramonte Llanes, et al.
Published: (2007-04-01)

Assessment of fibrosis and vascularization of bone marrow stroma of chronic myeloid Leukemia patients treated with imatinib mesylate and their relationship with the cytogenetic response
by: Caroline Regina de Jesus, et al.
Published: (2011-06-01)

Mesilato de Imatinibe para Tratamento da Leucemia Mielóide Crônica
by: Jane de Almeida Dobbin, et al.
Published: (2002-09-01)

Tratamento da recidiva da leucemia mielóide crônica após transplante de medula óssea alogênico utilizando mesilato de imatinibe: relato de três casos Treatment of chronic myelogenous leukemia relapse after allogeneic bone marrow transplantation with imatinib mesylate: report of three cases
by: Ronald Pallotta, et al.
Published: (2006-06-01)

O MESILATO DE IMATINIBE COMO TRATAMENTO PARA INIBIR A PROLIFERAÇÃO DAS CÉLULAS NEOPLÁSICAS EM PACIENTES COM LEUCEMIA MIELOIDE CRÔNICA.
by: Matias Nunes Frizzo, et al.
Published: (2016-08-01)

Análise de mutações do domínio BCR-ABL quinase em pacientes com leucemia mielóide crônica refratários ao tratamento com mesilato de imatinibe
by: Laine Celestino Pinto, et al.
Published: (2020-12-01)

Leucemia Mielóide Crônica em pediatria: perspectivas atuais Chronic Myeloid Leukemia in pediatrics patients: current approach
by: Maria Lucia M. Lee
Published: (2008-04-01)

Os desafios no tratamento da Leucemia mielóide crônica na era do mesilato de imatinibe Challenges in current chronic myeloid leukemia therapy of imatinib era
by: Cármino Antônio de Souza, et al.
Published: (2004-12-01)

O Impacto das Alterações Cromossômicas Adicionais em Resposta ao Mesilato de Imatinibe na Leucemia Mielóide Crônica
by: Luize Otero, et al.
Published: (2007-12-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-07-01)

Imatinib Mesylate (Glivec) in Pediatric Chronic Myelogenous Leukemia
by: Gholamreza Bahoush, et al.
Published: (2009-09-01)

Effect of astaxanthin in imatinib mesylate-induced cardiotoxicity
by: İshak Suat Övey, et al.
Published: (2020-03-01)

Leucemia Mielóide Crônica: causas de falha do tratamento com mesilato de imatinibe Chronic Myeloid Leukemia: causes of treatment failure with imatinib
by: Katia B. B. Pagnano
Published: (2008-04-01)

Melasma-like hyperpigmentation: A rare side effect of imatinib mesylate
by: Shreya Agrawal, et al.
Published: (2023-01-01)

Tratamiento de la leucemia mieloide crónica con mesilato de imatinib en pacientes resistentes o intolerantes al interferón alfa recombinante: Resultados preliminares Chronic myeloid leukemia treated with Imatinib Mesilate in patients resistant to or intolerant to recombinant alpha Interferon: Preliminary studies
by: Edgardo Espinosa Martínez, et al.
Published: (2010-03-01)

OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01)

Frequency of the BCR/ABL rearrangements and associated alterations detected by FISH during monitoring of patients taking imatinib mesylate in isolation Freqüência do rearranjo BCR/ABL e alterações associadas detectadas por FISH no monitoramento de pacientes em uso exclusivo do mesilato de imatinibe
by: Cristina B. Vendrame-Goloni, et al.
Published: (2006-06-01)

Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)
by: Ladislav Chrobák, et al.
Published: (2003-01-01)

Generalized lichenoid drug eruption associated with imatinib mesylate therapy
by: Sudip Kumar Ghosh
Published: (2013-01-01)

Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01)

Desarrollo normal del embarazo en dos pacientes con leucemia mieloide crónica tratadas con interferón-a
by: Onel M Avila-Cabrera, et al.

Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?
by: Olga Meltem Akay, et al.
Published: (2016-05-01)

OUR EXPERIENCE IN TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Marjana Glaser, et al.
Published: (2004-04-01)

Injectable Gamboge-Based In Situ Gel for Sustained Delivery of Imatinib Mesylate
by: Kritamorn Jitrangsri, et al.
Published: (2023-09-01)

Outcome of imatinib mesylate in women with child-bearing age diagnosed with chronic myeloid leukemia
by: Alaa Fadhil Alwan, et al.
Published: (2021-01-01)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
by: Hyun Jin Oh, et al.
Published: (2013-08-01)

Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia
by: G.A.P. Oliveira, et al.
Published: (2010-06-01)

Reacciones adversas del imatinib como droga de segunda línea en pacientes con leucemia mieloide crónica Adverse reactions to imatinib as second-line drug in patients with chronic myeloid leukemia
by: Onel M. Ávila Cabrera, et al.
Published: (2010-12-01)

Optimization Studies on Imatinib Mesylate Loaded Nanoliposomes Using Box-Behnken Design
by: Mandeep Dahiya, et al.
Published: (2022-03-01)

In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
by: Xu H, et al.
Published: (2021-02-01)

A rare complication of imatinib mesylate therapy: drug-induced pneumonitis
by: Ol'ga Veniaminovna Stakhina, et al.
Published: (2010-02-01)

Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants
by: Gholamreza Azizi, et al.
Published: (2014-06-01)

Dermatofibrosarcoma: report of a case with complete response to imatinib and conservative surgery during the COVID-19 pandemic
by: Rafael Martins Steffen, et al.
Published: (2022-10-01)

Influência do imatinibe no resultado do TMO e sua eficácia no tratamento da recaída The effect of prior exposure to imatinib on transplant outcomes and its effectiveness for relapse treatment
by: Afonso Celso Vigorito
Published: (2008-04-01)

Proposta de Acompanhamento Farmacoterapêutico em Leucemia Mieloide Crônica: Modelo de Abordagem Metodológica
by: Roberta Bitencourt Moreira, et al.
Published: (2009-12-01)

Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
by: Alexandra Rodrigues Alves, et al.

Molecular Mobility and Stability Studies of Amorphous Imatinib Mesylate
by: Bożena Karolewicz, et al.
Published: (2019-07-01)